Approval · Notice of Compliance 2293 · 2001
SEPTOPAL: Notice of Compliance 2293
Issued April 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2293
- Date
- April 30, 2001
- Company
- Biomet Orthopedics, Inc.Warsaw, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEPTOPAL | 00646350 | Cancelled Post Market |
Medicinal ingredients
- GENTAMICIN SULFATE 7.5 MG per IMP